Is Polypid Ltd (PYPD) Stock About to Get Hot Thursday?

Thursday, September 21, 2023 01:56 PM | InvestorsObserver Analysts

Mentioned in this article

Is Polypid Ltd (PYPD) Stock About to Get Hot Thursday?

Overall market sentiment has been high on Polypid Ltd (PYPD) stock lately. PYPD receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Polypid Ltd has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PYPD!

See Full PYPD Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With PYPD Stock Today?

Polypid Ltd (PYPD) stock is trading at $6.12 as of 1:44 PM on Thursday, Sep 21, a decline of -$1.23, or -16.77% from the previous closing price of $7.35. The stock has traded between $5.13 and $7.50 so far today. Volume today is above average. So far 49,743 shares have traded compared to average volume of 5,333 shares.

More About Polypid Ltd

PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies. Click Here to get the full Stock Report for Polypid Ltd stock.